R. Smith Kevin's most recent trade in Inogen Inc was a trade of 90,036 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 90,036 | 90,036 | - | - | Restricted Stock Unit | |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 53,975 | 84,662 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 28,333 | 56,667 | - | - | Restricted Stock Unit | |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 28,333 | 44,387 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 28 Feb 2025 | 26,097 | 58,565 (0%) | 0% | 8.3 | 217,388 | Common Stock |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 28 Feb 2025 | 13,700 | 30,687 (0%) | 0% | 8.3 | 114,121 | Common Stock |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 8.56 per share. | 28 Feb 2025 | 11,709 | 70,274 (0%) | 0% | 8.6 | 100,245 | Common Stock |
Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 8.33 per share. | 28 Feb 2025 | 1,500 | 16,054 (0%) | 0% | 8.3 | 12,495 | Common Stock |
Inogen Inc | Smith R. Kevin | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 28,333 | 28,333 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | R. Smith Kevin | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 28,333 | 56,667 | - | - | Restricted Stock Unit | |
Inogen Inc | Smith R. Kevin | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 01 Dec 2024 | 13,779 | 14,554 (0%) | 0% | 9.7 | 133,794 | Common Stock |
Inogen Inc | Kevin R. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 85,000 | 85,000 | - | - | Restricted Stock Unit | |
Inogen Inc | Smith Kevin R. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2023 | 85,000 | 85,000 | - | - | Restricted Stock Unit |